CT-derived Radiomics Predicts the Efficacy of Tyrosine Kinase Inhibitors in Osteosarcoma Patients with Pulmonary Metastasis
Background: To construct and validate the CT-based radiomics model for predicting the tyrosine kinase inhibitors (TKIs) effects in osteosarcoma (OS) patients with pulmonary metastasis. Methods: OS patients with pulmonary metastasis treated with TKIs were randomly separated into training and testing...
| Published in: | Translational Oncology |
|---|---|
| Main Authors: | Shanshui Zhou, Qi Liu, Yucheng Fu, Lianjun Du, Qiyuan Bao, Zhusheng Zhang, Zhihan Xu, Fuhua Yan, Meng Li, Ruixuan Liu, Le Qin, Weibin Zhang |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-07-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324001207 |
Similar Items
Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa
by: Ahmad Assi, et al.
Published: (2023-12-01)
by: Ahmad Assi, et al.
Published: (2023-12-01)
Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
by: Ming Zeng, et al.
Published: (2024-03-01)
by: Ming Zeng, et al.
Published: (2024-03-01)
Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
by: Emmy D. G. Fleuren, et al.
Published: (2023-03-01)
by: Emmy D. G. Fleuren, et al.
Published: (2023-03-01)
Clinical-radiomics models based on plain X-rays for prediction of lung metastasis in patients with osteosarcoma
by: Ping Yin, et al.
Published: (2023-03-01)
by: Ping Yin, et al.
Published: (2023-03-01)
Application and progress of X‐ray, computed tomography, and magnetic resonance imaging radiomics in osteosarcoma
by: Teng Peihong, et al.
Published: (2023-09-01)
by: Teng Peihong, et al.
Published: (2023-09-01)
Radiomics for predicting sensitivity to neoadjuvant chemotherapy in osteosarcoma: current status and advances
by: Panhong Zhang, et al.
Published: (2025-10-01)
by: Panhong Zhang, et al.
Published: (2025-10-01)
An updated systematic review of radiomics in osteosarcoma: utilizing CLAIM to adapt the increasing trend of deep learning application in radiomics
by: Jingyu Zhong, et al.
Published: (2022-08-01)
by: Jingyu Zhong, et al.
Published: (2022-08-01)
Construction and validation of a novel apoptosis-associated prognostic signature related to osteosarcoma metastasis and immune infiltration
by: Yucheng Fu, et al.
Published: (2022-08-01)
by: Yucheng Fu, et al.
Published: (2022-08-01)
Evaluation of the neoadjuvant chemotherapy response in osteosarcoma using the MRI DWI-based machine learning radiomics nomogram
by: Lu Zhang, et al.
Published: (2024-03-01)
by: Lu Zhang, et al.
Published: (2024-03-01)
Radiomics Analysis of Multiparametric MRI for Prediction of Synchronous Lung Metastases in Osteosarcoma
by: Zhendong Luo, et al.
Published: (2022-02-01)
by: Zhendong Luo, et al.
Published: (2022-02-01)
Radiomics analysis in differentiating osteosarcoma and chondrosarcoma based on T2-weighted imaging and contrast-enhanced T1-weighted imaging
by: Zhi Gao, et al.
Published: (2024-11-01)
by: Zhi Gao, et al.
Published: (2024-11-01)
A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
by: Peng Lin, et al.
Published: (2020-01-01)
by: Peng Lin, et al.
Published: (2020-01-01)
Osteosarcoma: current insights and advances
by: Guraustin S. Brar, et al.
Published: (2025-06-01)
by: Guraustin S. Brar, et al.
Published: (2025-06-01)
Cardiac metastasis of osteosarcoma
by: Sahin Hilal, et al.
Published: (2010-10-01)
by: Sahin Hilal, et al.
Published: (2010-10-01)
Exosome‐transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma
by: Qiming Li, et al.
Published: (2020-09-01)
by: Qiming Li, et al.
Published: (2020-09-01)
Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasis
by: Yucheng Fu, et al.
Published: (2021-02-01)
by: Yucheng Fu, et al.
Published: (2021-02-01)
Inhibition of protein kinase C activity inhibits osteosarcoma metastasis
by: He-Jun Hu, et al.
Published: (2018-11-01)
by: He-Jun Hu, et al.
Published: (2018-11-01)
LIM Kinases in Osteosarcoma Development
by: Régis Brion, et al.
Published: (2021-12-01)
by: Régis Brion, et al.
Published: (2021-12-01)
Radiomics of metastatic brain tumor as a predictive image biomarker of progression-free survival in patients with non-small-cell lung cancer with brain metastasis receiving tyrosine kinase inhibitors
by: Ting-Wei Wang, et al.
Published: (2024-01-01)
by: Ting-Wei Wang, et al.
Published: (2024-01-01)
Extremely Rapid Gelling Curcumin Silk-Tyrosine Crosslinked Hydrogels
by: Aswin Sundarakrishnan
Published: (2025-04-01)
by: Aswin Sundarakrishnan
Published: (2025-04-01)
Osteosarcoma Cell‐Derived Migrasomes Promote Macrophage M2 Polarization to Aggravate Osteosarcoma Proliferation and Metastasis
by: Wanshun Liu, et al.
Published: (2025-05-01)
by: Wanshun Liu, et al.
Published: (2025-05-01)
Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
by: Jiuhui Xu, et al.
Published: (2023-06-01)
by: Jiuhui Xu, et al.
Published: (2023-06-01)
Primary osteosarcoma of the breast
by: Hung-An Huang, et al.
Published: (2021-01-01)
by: Hung-An Huang, et al.
Published: (2021-01-01)
PKIB involved in the metastasis and survival of osteosarcoma
by: Rongxue Wan, et al.
Published: (2022-08-01)
by: Rongxue Wan, et al.
Published: (2022-08-01)
Brain Metastasis in Pediatric Patients with Osteosarcoma
by: Jacob Murphy, et al.
Published: (2024-11-01)
by: Jacob Murphy, et al.
Published: (2024-11-01)
From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond
by: Yu Zhou, et al.
Published: (2024-07-01)
by: Yu Zhou, et al.
Published: (2024-07-01)
Different Subtypes of Osteosarcoma: Histopathological Patterns and Clinical Behaviour
by: Emel Rothzerg, et al.
Published: (2023-05-01)
by: Emel Rothzerg, et al.
Published: (2023-05-01)
Overexpression of klotho suppresses growth and pulmonary metastasis of osteosarcoma in vivo
by: Ying Li, et al.
by: Ying Li, et al.
Editorial: Tyrosine kinases and phosphatases in T- cell malignancies
by: Melania Tesio
Published: (2024-02-01)
by: Melania Tesio
Published: (2024-02-01)
Analysis of intracellular tyrosine phosphorylation in circulating neutrophils as a rapid assay for the in vivo effect of oral tyrosine kinase inhibitors
by: Krisztina Futosi, et al.
Published: (2023-04-01)
by: Krisztina Futosi, et al.
Published: (2023-04-01)
Current understanding of tyrosine kinase BMX in inflammation and its inhibitors
by: Le Qiu, et al.
Published: (2014-07-01)
by: Le Qiu, et al.
Published: (2014-07-01)
Case report: A study on the pathology of mandibular osteosarcoma with hepatic metastasis in a giant panda
by: Zongliang Xiong, et al.
Published: (2025-02-01)
by: Zongliang Xiong, et al.
Published: (2025-02-01)
Dual‐polarization 3D FSR with a high selectivity and wide transmission passband
by: Yuchen Yan, et al.
Published: (2024-12-01)
by: Yuchen Yan, et al.
Published: (2024-12-01)
A comparison of risk factors for metastasis at diagnosis in humans and dogs with osteosarcoma
by: Brandon J. Diessner, et al.
Published: (2019-06-01)
by: Brandon J. Diessner, et al.
Published: (2019-06-01)
Intratibial osteosarcoma growth and pulmonary metastasis inhibition by HIPPO signaling pathway-induced photodynamic therapy
by: Wenyi Wang, et al.
Published: (2023-09-01)
by: Wenyi Wang, et al.
Published: (2023-09-01)
Biological Activity of Biomarkers Associated With Metastasis in Osteosarcoma Cell Lines
by: Nidia Ednita Beltrán‐Hernández, et al.
Published: (2025-03-01)
by: Nidia Ednita Beltrán‐Hernández, et al.
Published: (2025-03-01)
Construction and validation of nomogram to predict distant metastasis in osteosarcoma: a retrospective study
by: Shouliang Lu, et al.
Published: (2021-03-01)
by: Shouliang Lu, et al.
Published: (2021-03-01)
Tyrosine kinase inhibitors in Ewing’s sarcoma: a systematic review
by: Ahmad Assi, et al.
Published: (2025-04-01)
by: Ahmad Assi, et al.
Published: (2025-04-01)
A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma
by: Binhao Shi, et al.
Published: (2023-06-01)
by: Binhao Shi, et al.
Published: (2023-06-01)
Lenvatinib Monotherapy Versus Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Osteosarcoma: A Real-World Study
by: Song G, et al.
Published: (2025-02-01)
by: Song G, et al.
Published: (2025-02-01)
Similar Items
-
Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa
by: Ahmad Assi, et al.
Published: (2023-12-01) -
Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
by: Ming Zeng, et al.
Published: (2024-03-01) -
Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
by: Emmy D. G. Fleuren, et al.
Published: (2023-03-01) -
Clinical-radiomics models based on plain X-rays for prediction of lung metastasis in patients with osteosarcoma
by: Ping Yin, et al.
Published: (2023-03-01) -
Application and progress of X‐ray, computed tomography, and magnetic resonance imaging radiomics in osteosarcoma
by: Teng Peihong, et al.
Published: (2023-09-01)
